Diprosalic

Package Leaflet: Information for the Patient

Warning! Keep the leaflet, the information on the immediate packaging is in a foreign language!

Diprosalic(Diprosalic Ointment)
(0.64 mg + 30 mg)/g, ointment
Betamethasone dipropionate + Salicylic acid
Diprosalic and Diprosalic Ointment are different trade names for the same drug.

Read the leaflet carefully before using the medicine, as it contains important information for the patient.

• Keep this leaflet, so you can read it again if you need to.
• If you have any doubts, consult your doctor or pharmacist.
• This medicine has been prescribed specifically for you. Do not pass it on to others. The medicine may harm another person, even if their symptoms are the same.
• If the patient experiences any side effects, including any side effects not listed in this leaflet, they should tell their doctor or pharmacist. See section 4.

Table of Contents of the Leaflet

• 1. What is Diprosalic and what is it used for
• 2. Important information before using Diprosalic
• 3. How to use Diprosalic
• 4. Possible side effects
• 5. How to store Diprosalic
• 6. Contents of the pack and other information

1. What is Diprosalic and what is it used for

Diprosalic ointment contains the active substances: betamethasone dipropionate and salicylic acid. Betamethasone dipropionate is a synthetic fluorinated corticosteroid with strong action; when used topically, it has anti-inflammatory, anti-itching, and vasoconstrictive effects.
Salicylic acid, when used topically, softens keratin and thickened skin and exfoliates the skin, facilitating the penetration of betamethasone dipropionate into the skin.

Indications

Diprosalic is indicated for the topical treatment of acute and chronic skin diseases, such as: psoriasis, severe forms of atopic dermatitis, limited neurodermatitis, lichen planus, severe forms of eczema (including nummular eczema and contact eczema).

2. Important information before using Diprosalic

When not to use Diprosalic:

• on facial skin;

Warnings and precautions

Before starting treatment with Diprosalic, discuss it with your doctor or pharmacist.
Avoid using the medicine on a large area of the body, especially in children.
If symptoms of irritation, allergy, or excessive dryness of the skin appear during treatment with Diprosalic, discontinue use and consult a doctor.
If bacterial infections occur, the doctor will prescribe appropriate antibacterial treatment.
During treatment, side effects similar to those that occur with systemic corticosteroids may occur, including adrenal insufficiency. Therefore, avoid using the medicine on a large area of skin, wounds, damaged skin, using the medicine in large doses, and prolonged use. If necessary, use the medicine in such cases, take special precautions.
Be especially cautious when using the medicine in psoriasis. Using the medicine in psoriasis can lead to a relapse of the disease due to the development of tolerance, the occurrence of generalized pustular psoriasis, and systemic toxic effects related to skin barrier disruption.
The medicine should not be used under occlusive dressings, as it may increase percutaneous absorption of the corticosteroid.
Do not use in the eyes.
Avoid contact of the medicine with the eyes and mucous membranes.
Use with caution in children. In children, it is easier than in adults to cause suppression of the hypothalamic-pituitary-adrenal axis and the occurrence of side effects characteristic of corticosteroids.
In children treated with topical corticosteroids, suppression of the hypothalamic-pituitary-adrenal axis, Cushing's syndrome, growth retardation, decreased weight gain, and intracranial hypertension have been reported.
If the patient experiences blurred vision or other vision disturbances, consult a doctor.

Children

Do not use in children under 12 years of age.

Diprosalic and other medicines

No data available.
Tell your doctor or pharmacist about all medicines you are taking, have recently taken, or plan to take.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a baby, consult your doctor or pharmacist before using this medicine.
No data are available on the topical use of corticosteroids in pregnant women. Diprosalic can be used only when the potential benefit to the mother outweighs the possible risk to the fetus.
It is not known whether topically applied corticosteroids pass into breast milk. A decision should be made to either discontinue breastfeeding or discontinue Diprosalic, taking into account the benefit of breastfeeding to the baby and the benefit of treatment to the mother.

Driving and using machines

Diprosalic has no effect on the ability to drive and use machines.

3. How to use Diprosalic

This medicine should always be used as directed by your doctor. If you are unsure, consult your doctor or pharmacist.
This medicine is for use on the skin.

Adults and children over 12 years of age

Usually, a small amount of the medicine (0.2-0.5 cm of ointment per 10 cm of skin surface) is applied to the affected areas of the skin and gently rubbed in twice a day (morning and evening).
In some cases, the doctor may recommend less frequent use of the medicine. Treatment should not last longer than 14 days. If the disease recurs, the doctor will consider whether treatment can be repeated.
Do not use the medicine in children under 12 years of age.
If you feel that the effect of Diprosalic is too strong or too weak, consult your doctor.

Using a higher dose of Diprosalic than recommended

Prolonged use of the medicine can lead to suppression of the hypothalamic-pituitary-adrenal axis and, consequently, to secondary adrenal insufficiency, as well as to hypercorticism, including Cushing's syndrome.
Additionally, prolonged or high-dose use of the medicine may cause salicylic acid poisoning.
In case of overdose, the doctor will provide appropriate symptomatic treatment. Acute symptoms of corticosteroid overdose are usually reversible. If necessary, the doctor will correct electrolyte levels and, in case of chronic poisoning, will recommend gradual, step-by-step withdrawal of the medicine.
In case of salicylic acid poisoning, the doctor will take actions to quickly remove salicylates from the patient's body.

Missing a dose of Diprosalic

Do not use a double dose to make up for a missed dose.

4. Possible side effects

Like all medicines, Diprosalic can cause side effects, although not everybody gets them.
During treatment with Diprosalic, the following side effects may occur: burning, itching, irritation, dryness of the skin, folliculitis, hypertrichosis, acne-like changes, skin depigmentation, perioral dermatitis, allergic contact dermatitis, skin maceration, secondary infections, skin atrophy, striae, and furuncles. Due to the fact that the medicine contains salicylic acid, skin inflammation may occur during prolonged use.
As a result of the absorption of active substances into the blood, general side effects of betamethasone (characteristic of corticosteroids) and salicylic acid may also occur.
General side effects occur mainly in case of prolonged use of the medicine, use on a large area of skin, and use in children.
During the use of corticosteroids, blurred vision (frequency not known - cannot be estimated from available data) has been observed.

Reporting side effects

If you experience any side effects, including any side effects not listed in this leaflet, tell your doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products: Al. Jerozolimskie 181C, 02-222 Warsaw, Tel.: +48 22 49 21 301, Fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl.
Side effects can also be reported to the marketing authorization holder or parallel importer.
By reporting side effects, you can help provide more information on the safety of this medicine.

5. How to store Diprosalic

Store below 25°C.
Keep the medicine out of the sight and reach of children.
Use within 3 months of opening.
Do not use this medicine after the expiry date stated on the packaging.
The expiry date refers to the last day of the month.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.

6. Contents of the pack and other information

What Diprosalic contains

• The active substances of the medicine are betamethasone dipropionate and salicylic acid. Each gram of ointment contains 0.64 mg of betamethasone dipropionate (equivalent to 0.5 mg of betamethasone) and 30 mg of salicylic acid.
• The other ingredients are: white petrolatum and liquid paraffin.

What Diprosalic looks like and contents of the pack

Diprosalic is an ointment.
Available packs:
Aluminum tube in a cardboard box containing 30 g of ointment.
For more detailed information, consult the marketing authorization holder or parallel importer.

Marketing authorization holder in Spain, the country of export:

Organon Salud, S.L.
Paseo de la Castellana, 77
28046 Madrid
Spain

Manufacturer:

Organon Heist bv
Industriepark 30
2220 Heist-op-den-Berg
Belgium

Parallel importer:

Medezin Sp. z o.o.
ul. Zbąszyńska 3
91-342 Łódź

Repackaged by:

Medezin Sp. z o.o.
ul. Zbąszyńska 3
91-342 Łódź
Marketing authorization number in Spain, the country of export: 656810.1
Parallel import authorization number: 363/24

Date of approval of the leaflet: 17.10.2024

[Information about the trademark]